Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Edoxaban | hsa00190 | Oxidative phosphorylation | 1.10E-03 | 3 | Q16718, P36542, O14521 | NDUFA5, ATP5C1, SDHD | More | | Edoxaban | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Edoxaban | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Edoxaban | hsa03013 | RNA transport | 1.39E-04 | 12 | O14980, Q09161, O14893, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9BZI7, Q06787, P51114 | XPO1, NCBP1, GEMIN2, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, UPF3B, FMR1, FXR1 | More | | Edoxaban | hsa03022 | Basal transcription factors | 2.97E-03 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Edoxaban | hsa03040 | Spliceosome | 1.26E-02 | 6 | P17844, P51991, P61978, Q15365, Q01130, P11142 | DDX5, HNRPA3, HNRPK, PCBP1, SFRS2, HSPA8 | More | | Edoxaban | hsa03060 | Protein export | 3.37E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Edoxaban | hsa04141 | Protein processing in endoplasmic reticulum | 6.04E-03 | 8 | P18848, Q15437, Q99941, O75460, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Edoxaban | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Edoxaban | hsa04151 | PI3K-Akt signaling pathway | 9.80E-03 | 10 | O43521, P27348, Q13362, P07900, P22105, P23458, Q99941, P18848, O00141, Q6ZUJ8 | BCL2L11, YWHAQ, PPP2R5C, HSP90AA1, TNXB, JAK1, CREBL1, ATF4, SGK, PIK3AP1 | More | | Edoxaban | hsa04211 | Longevity regulating pathway | 4.57E-02 | 4 | P51828, Q99941, P18848, Q96RR4 | ADCY7, CREBL1, ATF4, CAMKK2 | More | | Edoxaban | hsa04217 | Necroptosis | 5.00E-03 | 7 | P23458, Q9NQC7, P07900, P05141, P01584, Q9H444, O75351 | JAK1, CYLD, HSP90AA1, SLC25A5, IL1B, CHMP4B, VPS4B | More | | Edoxaban | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.26E-02 | 6 | P67936, P51828, Q99941, P18848, Q13362, P23634 | TPM4, ADCY7, CREBL1, ATF4, PPP2R5C, ATP2B4 | More | | Edoxaban | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Edoxaban | hsa04613 | Neutrophil extracellular trap formation | 4.20E-02 | 5 | P04908, Q93077, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | | Edoxaban | hsa04621 | NOD-like receptor signaling pathway | 2.39E-02 | 5 | P01584, P07900, P23458, Q9H3M7, P43490 | IL1B, HSP90AA1, JAK1, TXNIP, PBEF1 | More | | Edoxaban | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Edoxaban | hsa04911 | Insulin secretion | 4.85E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Edoxaban | hsa04915 | Estrogen signaling pathway | 1.65E-02 | 6 | Q99941, P18848, P51828, P07900, P11142, Q15788 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8, NCOA1 | More | | Edoxaban | hsa04918 | Thyroid hormone synthesis | 2.50E-02 | 4 | P51828, Q99941, P18848, P05543 | ADCY7, CREBL1, ATF4, SERPINA7 | More | | Edoxaban | hsa04925 | Aldosterone synthesis and secretion | 2.50E-02 | 4 | Q99941, P18848, P51828, P23634 | CREBL1, ATF4, ADCY7, ATP2B4 | More | | Edoxaban | hsa04927 | Cortisol synthesis and secretion | 3.29E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Edoxaban | hsa04932 | Non-alcoholic fatty liver disease | 3.62E-02 | 3 | P49841, Q16718, O14521 | GSK3B, NDUFA5, SDHD | More | | Edoxaban | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Edoxaban | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Edoxaban | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | | Edoxaban | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | | Edoxaban | hsa05133 | Pertussis | 2.24E-02 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Edoxaban | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Edoxaban | hsa05150 | Staphylococcus aureus infection | 4.02E-03 | 6 | P21462, O75015, Q14532, P59665, P59666, P12838 | FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Edoxaban | hsa05163 | Human cytomegalovirus infection | 4.52E-02 | 7 | P51828, P23458, P01584, P61073, Q13651, Q99941, P18848 | ADCY7, JAK1, IL1B, CXCR4, IL10RA, CREBL1, ATF4 | More | | Edoxaban | hsa05203 | Viral carcinogenesis | 1.26E-02 | 6 | Q99941, P18848, P23458, P27348, Q7KZF4, P61978 | CREBL1, ATF4, JAK1, YWHAQ, SND1, HNRPK | More | | Edoxaban | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | |